The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Phenotypic difference of normal plasma cells from mature myeloma cells
Open accessAbstract
We have recently shown that two-color analysis with fluorescein isothiocyanate (FITC)-anti-CD38 antibody could clearly distinguish myeloma cells (plasma cells) from other hematopoietic cells in the bone marrow. Myeloma cells (plasma cells) alone were located at CD38strong positive (++) fractions. To further distinguish normal plasma cells from mature myeloma cells phenotypically, we examined immunophenotypes of normal plasma cells and myeloma cells by two-color flow cytometry with FITC-anti-CD38 antibody and phycoerythrin staining with antibody to VLA-4, MPC-1, CD44, CD56, CD19, CD20, CD24, or CD10. Normal plasma cells were all VLA-4+VLA-5+MPC-1+CD44+ CD19+CD56- in the bone marrows from seven healthy donors, tonsils from four patients with chronic tonsillitis, a spleen from one patient with idiopathic thrombocytopenic purpura, and lymph nodes from two patients with chronic lymphadenitis, respectively. On the other hand, mature myeloma cells (12 of 20 cases), VLA-4+VLA-5+MPC-1+, were all CD19- and most of them CD56+, and there were no myeloma cells with the CD19+CD56- phenotype in the 20 cases of myelomas we tested. Thus, as for the expression of CD19 and CD56, normal plasma cells from various tissues are all CD19+CD56-, whereas no myeloma cells have the CD19+CD56- phenotype. According to this finding, we investigated the expression of CD19 and CD56 on plasma cells (CD38++ fractions) in monoclonal gammopathy of undetermined significance (MGUS). Both CD19+CD56- and CD19-DC56+ plasma cells were found in all five cases of MGUS we tested, suggesting that MGUS consists of phenotypically normal plasma cells and myeloma cells. Therefore, it is reasoned that phenotypic analysis of plasma cells with anti-CD19 and anti-CD56 antibodies can distinguish normal plasma cells from malignant plasma cells (myeloma cells), and can detect malignant plasma cells even in MGUS or premyeloma states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anderson, K., Bates, M., Slaughenhoupt, B., Pinkus, G., Schlossman, S., & Nadler, L. (1984) · Blood · doi:10.1182/blood.v63.6.1424.1424 · Cited by 704
Cell Adhesion Molecules in the Regulation of Animal Form and Tissue Pattern
Edelman, G. M. (1986) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.02.110186.000501 · Cited by 628
Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule.
Lanier, L. L., Testi, R., Bindl, J., & Phillips, J. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.6.2233 · Cited by 494
Van Camp, B., Durie, B., Spier, C., De Waele, M., Van Riet, I., Vela, E., Frutiger, Y., Richter, L., & Grogan, T. (1990) · Blood · doi:10.1182/blood.v76.2.377.377 · Cited by 307
Multiple myeloma: significance of plasmablastic subtype in morphological classification
Greipp, P., Raymond, N., Kyle, R., & O'Fallon, W. (1985) · Blood · doi:10.1182/blood.v65.2.305.305 · Cited by 263
Terstappen, L., Johnsen, S., Segers-Nolten, I., & Loken, M. (1990) · Blood · doi:10.1182/blood.v76.9.1739.1739 · Cited by 259
Expression of cell surface markers after human B lymphocyte activation.
Stashenko, P., Nadler, L. M., Hardy, R., & Schlossman, S. F. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3848 · Cited by 212
Identification of immature and mature myeloma cells in the bone marrow of human myelomas
Kawano, M., Huang, N., Harada, H., Harada, Y., Sakai, A., Tanaka, H., Iwato, K., & Kuramoto, A. (1993) · Blood · doi:10.1182/blood.v82.2.564.564 · Cited by 136
Self-citationMyelomonocytic antigen positive multiple myeloma
Grogan, T., Durie, B., Spier, C., Richter, L., & Vela, E. (1989) · Blood · doi:10.1182/blood.v73.3.763.763 · Cited by 106
Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells
Riet, I. V., Waele, M. D., Remels, L., et al. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08050.x · Cited by 100
Cited by
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Kochenderfer, J. N., Wilson, W. H., Janik, J. E., Dudley, M. E., Stetler-Stevenson, M., Feldman, S. A., Maric, I., Raffeld, M., Nathan, D.-A. N., Lanier, B. J., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281931 · Cited by 1,337
on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., van Dongen, J. J. M., Lhermitte, L., Böttcher, S., Almeida, J., van der Velden, V. H. J., Flores-Montero, J., Rawstron, A., Asnafi, V, Lécrevisse, Q., et al. (2012) · Leukemia · doi:10.1038/leu.2012.120 · Cited by 934
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
Hallek, M., Leif Bergsagel, P., & Anderson, K. C. (1998) · Blood · doi:10.1182/blood.v91.1.3 · Cited by 752
Analysis of islet inflammation in human type 1 diabetes
Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03860.x · Cited by 712
Metadata
- Authors
- Harada, H., Kawano, M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H., & Kuramoto, A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1993-05-15
- Volume
- 81
- Issue
- 10
- Pages
- 2658-2663
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1498837690
- Cited by
- 355
- References
- 17
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenotypic difference of normal plasma cells from mature myeloma cells. https://app.cochat.ai/papers/10.1182/blood.v81.10.2658.2658
- The paper
- Harada, H., Kawano, M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H., & Kuramoto, A. (1993). Phenotypic difference of normal plasma cells from mature myeloma cells. Blood. https://doi.org/10.1182/blood.v81.10.2658.2658
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.